While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, ...

Tuberculosis (TB) remains one of the world's most serious public health threats, with approximately one-quarter of the global population infected with Mycobacterium tuberculosis. While most infections ...

Texas Biomedical Research Institute has established a new $2 million Tuberculosis Innovation and Technology Fund supported by philanthropic investment to accelerate future TB discoveries, therapies ...

Tuberculosis (TB) remains one of the world's most serious public health threats, with approximately one-quarter of the global population infected with Mycobacterium tuberculosis. While most infections ...

The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial ...

A phase-3 trial published in The British Medical Journal finds two new TB vaccines, VPM1002 and Immuvac, safe for use in India but not effective against all forms of tuberculosis, though they may help ...

Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) ...

Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do not offer protection ...

Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease ...

A 76-year-old man on cancer immunotherapy developed a mixed Mycobacterium tuberculosis and Aspergillus fumigatus empyema with pneumothorax, exposing key diagnostic and therapeutic gaps.